General form of registration statement for all companies including face-amount certificate companies

SHAREHOLDERS' EQUITY

v3.21.2
SHAREHOLDERS' EQUITY
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
STOCKHOLDERS' EQUITY    
8. SHAREHOLDERS' EQUITY

8. SHAREHOLDERS’ EQUITY

 

Shares Outstanding

 

The table below details the change in Company shares outstanding by class during the six months ended June 30, 2021:

 

 

 

Subordinate

 

 

Super

 

(in thousands)

 

Voting Shares

 

 

Voting Shares

 

Balance—December 31, 2020

 

 

57,617

 

 

 

203

 

Shares issued in connection with exercise of warrants

 

 

1,325

 

 

 

-

 

Shares issued in connection with conversion of convertible debentures

 

 

2,393

 

 

 

-

 

Shares issued in connection with asset acquisition

 

 

30,641

 

 

 

-

 

Issuance of vested restricted stock units

 

 

371

 

 

 

-

 

Stock issued in connection with exercised of stock options

 

 

76

 

 

 

-

 

Balance—June 30, 2021

 

 

92,423

 

 

 

203

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

 

 

 

Balance—December 31, 2020

 

 

 

 

 

 

93,898

 

Warrants issued in conjunction with broker option exercise (1)

 

 

 

 

 

 

163

 

Warrants expired

 

 

 

 

 

 

(358 )

Warrants converted into subordinate voting shares

 

 

 

 

 

 

(1,000 )

Balance—June 30, 2021

 

 

 

 

 

 

92,703

 

 

(1) Excluded 390 warrants issuable should underwriter options be exercised.

12. SHAREHOLDERS’ EQUITY

 

Shares Outstanding

 

The table below details the change in Company shares outstanding by class during the year ended December 31, 2020:

 

 

 

Subordinate

 

 

Super

 

(in thousands)

 

Voting Shares

 

 

Voting Shares

 

Balance—December 31, 2019

 

 

32,844

 

 

 

203

 

Shares issued in connection with convertible debenture offering

 

 

250

 

 

 

-

 

Shares issued in connection with subordinate voting share offering

 

 

23,000

 

 

 

-

 

Shares issued in connection with exercise of warrants

 

 

750

 

 

 

-

 

Shares issued in connection with conversion of convertible debentures

 

 

375

 

 

 

-

 

Shares issued in connection with asset purchase

 

 

150

 

 

 

-

 

Issuance of vested restricted stock units

 

 

248

 

 

 

-

 

Balance—December 31, 2020

 

 

57,617

 

 

 

203

 

 

In December 2020, the Company complete a CAD$34.5 million share offering resulting in the issuance of 11.5 million subordinate voting shares priced at CAD$1.50 per share. The offering resulting in approximately $25 million in proceeds, net of offering expenses. The use of proceeds were for the development of a cultivation and production facility and working capital and other corporate purposes.

 

As discussed in Note 4, in consideration for the acquisition of Mezzotin in connection with the reverse takeover, Indus issued 130 shares of Indus subordinate voting shares representing $1,513 total value based on the concurrent financing subscription price of CAD$15.65 (US$11.60). The excess of the purchase price over net assets acquired was charged to the consolidated statements of operations as RTO expense in general and administrative expenses.

 

Warrants

 

A reconciliation of the beginning and ending balance of warrants outstanding is as follows:

 

(in thousands)

 

 

 

Balance—December 31, 2019

 

 

2,769

 

Warrants issued in conjunction with convertible debenture offering

 

 

80,379

 

Warrants issued in conjunction with equity offering(1)

 

 

11,500

 

Warrants converted into subordinate voting shares

 

 

(750 )

Balance—December 31, 2020

 

 

93,898

 

_____________

(1) Excludes 553 warrants issuable should underwriter options be exercised.